# Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

> **NCT02364557** · PHASE2,PHASE3 · COMPLETED · sponsor: **NRG Oncology** · enrollment: 129 (actual)

## Conditions studied

- Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
- Metastatic Breast Carcinoma
- Metastatic Malignant Neoplasm in the Bone
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Malignant Neoplasm in the Lung
- Metastatic Malignant Neoplasm in the Lymph Nodes
- Metastatic Malignant Neoplasm in the Spine
- Prognostic Stage IV Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8

## Interventions

- **RADIATION:** Stereotactic Body Radiotherapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT02364557
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-24
- **Primary completion:** 2021-12-20
- **Final completion:** 2025-09-04
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02364557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02364557, "Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02364557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*